These issues of the weekly record include key information on pandemic influenza, along with other timely public health information.
4 December 2009, vol. 84, 49 (pp 505–516)
Pandemic influenza A (H1N1) 2009 virus vaccine – conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts
Global reductions in measles mortality 2000–2008 and the risk of measles resurgence
Pandemic influenza A (H1N1) 2009 virus vaccine – conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts
Global reductions in measles mortality 2000–2008 and the risk of measles resurgence
20 November 2009, vol. 84, 47 (pp 485–492)
Epidemiological summary of pandemic influenza A (H1N1) 2009 virus – Ontario, Canada, June 2009
Epidemiological summary of pandemic influenza A (H1N1) 2009 virus – Ontario, Canada, June 2009
13 November 2009, vol. 84, 46 (pp 477–484)
Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj)
Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus
Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj)
Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus
30 October 2009, vol. 84, 44 (pp 453–468)
Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009
Meeting of the International Task Force for Disease Eradication, June 2009
Monthly report on dracunculiasis cases, January–August 2009
WHO web sites on infectious disease
Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009
Meeting of the International Task Force for Disease Eradication, June 2009
Monthly report on dracunculiasis cases, January–August 2009
WHO web sites on infectious disease
4 September 2009, vol. 84, 36 (pp 361–372)
Global influenza surveillance network: laboratory surveillance and response to pandemic H1N1 2009
Global detection of wild and vaccine-derived polioviruses, January 2008–June 2009
Monthly report on dracunculiasis cases, January–July 2009
Global influenza surveillance network: laboratory surveillance and response to pandemic H1N1 2009
Global detection of wild and vaccine-derived polioviruses, January 2008–June 2009
Monthly report on dracunculiasis cases, January–July 2009
21 August 2009, vol. 84, 34 (pp 341–348)
Mathematical modelling of the pandemic H1N1 2009
Mathematical modelling of the pandemic H1N1 2009
24 July 2009, vol. 84, 30 (pp 301–308)
Strategic Advisory Group of Experts on Immunization – report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009
Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 – update
Strategic Advisory Group of Experts on Immunization – report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009
Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 – update
17 July 2009, vol. 84, 29 (pp 289–300)
Advisory Committee on Poliomyelitis Eradication: recommendations on the use of bivalent oral poliovirus vaccine types 1 and 3
Status of neonatal tetanus elimination in the United Republic of Tanzania – results from a lot quality-assurance cluster survey
Pandemic (H1N1) 2009 briefing note 1 – Viruses resistant to oseltamivir (Tamiflu) identified
Advisory Committee on Poliomyelitis Eradication: recommendations on the use of bivalent oral poliovirus vaccine types 1 and 3
Status of neonatal tetanus elimination in the United Republic of Tanzania – results from a lot quality-assurance cluster survey
Pandemic (H1N1) 2009 briefing note 1 – Viruses resistant to oseltamivir (Tamiflu) identified
10 July 2009, vol. 84, 28 (pp 281–288)
Progress towards poliomyelitis eradication in India, January 2007–May 2009
New influenza A (H1N1) virus – update
Progress towards poliomyelitis eradication in India, January 2007–May 2009
New influenza A (H1N1) virus – update
3 July 2009, vol. 84, 27 (pp 261–280)
Human infection with new influenza A (H1N1) virus: WHO Consultation on suspension of classes and restriction of mass gatherings to mitigate the impact of epidemics caused by influenza A (H1N1), May 2009
Progress towards the 2012 measles elimination goal in WHO’s Western Pacific Region, 1990–2008
Monthly report on dracunculiasis cases, January– May 2009
Human infection with new influenza A (H1N1) virus: WHO Consultation on suspension of classes and restriction of mass gatherings to mitigate the impact of epidemics caused by influenza A (H1N1), May 2009
Progress towards the 2012 measles elimination goal in WHO’s Western Pacific Region, 1990–2008
Monthly report on dracunculiasis cases, January– May 2009
26 June 2009, vol. 84, 26 (pp 261–268)
New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009
Drug resistance in leprosy: reports from selected endemic countries
Index of countries/areas
Subject Index, Volume 84, 2009, Nos. 1–26
New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009
Drug resistance in leprosy: reports from selected endemic countries
Index of countries/areas
Subject Index, Volume 84, 2009, Nos. 1–26
19 June 2009, vol. 84, 25 (pp 249–260)
New influenza A (H1N1) virus: global epidemiological situation, June 2009
Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2008
New influenza A (H1N1) virus: global epidemiological situation, June 2009
Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2008
12 June 2009, vol. 84, 24 (pp 227–248)
Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009
Strategic Advisory Group of Experts: recommendations on the use of licensed human H5N1 influenza vaccines in the interpandemic period
Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009
Strategic Advisory Group of Experts: recommendations on the use of licensed human H5N1 influenza vaccines in the interpandemic period
5 June 2009, vol. 84, 23 (pp 213–236)
Human infection with new influenza A (H1N1) virus: Mexico, update, March–May 2009
Meeting of the immunization Strategic Advisory Group of Experts, April 2009 – conclusions and recommendations
WHO web sites on infectious diseases
Human infection with new influenza A (H1N1) virus: Mexico, update, March–May 2009
Meeting of the immunization Strategic Advisory Group of Experts, April 2009 – conclusions and recommendations
WHO web sites on infectious diseases
29 May 2009, vol. 84, 22 (pp 197–212)
Considerations for assessing the severity of an influenza pandemic
Estimating the global burden of foodborne diseases: a collaborative effort
Monthly report on dracunculiasis cases, January–April 2009
Considerations for assessing the severity of an influenza pandemic
Estimating the global burden of foodborne diseases: a collaborative effort
Monthly report on dracunculiasis cases, January–April 2009
22 May 2009, vol. 84, 21 (pp 185–196)
Human infection with new infl uenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009
Leprosy in Yemen: trends in case detection, 1982–2008
Human infection with new infl uenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009
Leprosy in Yemen: trends in case detection, 1982–2008
15 May 2009, vol. 84, 20 (pp 173–184)
New influenza A(H1N1) virus infections: global surveillance summary, May 2009
The Paediatric Bacterial Meningitis Surveillance Network in WHO’s African Region, 2001–2008
New influenza A(H1N1) virus infections: global surveillance summary, May 2009
The Paediatric Bacterial Meningitis Surveillance Network in WHO’s African Region, 2001–2008
1 May 2009, vol. 84, 18 (pp 149–160)
Outbreak news
– Swine influenza
Swine influenza: frequently asked questions
Psychological health
-----------------------------------------------------------------------------------------------------------
Statements and speeches
Statement following the sixth meeting of the Emergency CommitteeOutbreak news
– Swine influenza
Swine influenza: frequently asked questions
Psychological health
-----------------------------------------------------------------------------------------------------------
Statements and speeches
Statement by WHO Director-General Dr Margaret Chan
26 November 2009
Agreement for donation of pandemic H1N1 vaccine signed
Statement
10 November 2009
Support for developing countries’ response to the H1N1 influenza pandemic
Joint Statement by the UN Secretary-General and the WHO Director-General
24 September 2009
Statement following the fifth meeting of the Emergency Committee
Statement by WHO Director-General Dr Margaret Chan
24 September 2009
Pandemic vaccine donations for the developing world
Statement by WHO Director-General Dr Margaret Chan
18 September 2009
Call to action from WHO, IFRC, UNSIC, OCHA and UNICEF
17 August 2009
Lessons learned and preparedness
Keynote speech at a high-level meeting on influenza A(H1N1)
Cancun, Quintana Roo, Mexico
2 July 2009
WHO welcomes sanofi-aventis's donation of vaccine
Statement by WHO Director-General Dr Margaret Chan
17 June 2009
World now at the start of 2009 influenza pandemic
Statement to the press by WHO Director-General Dr Margaret Chan
11 June 2009
Concern over flu pandemic justified
Address to Sixty-second World Health Assembly
Geneva, Switzerland
18 May 2009
Pandemic threat deserves attention from all
Remarks at the high-level consultation on pandemic influenza A(H1N1)
Geneva, Switzerland
18 May 2009
Sharing of influenza viruses, access to vaccines and other benefits
Opening remarks at the Intergovernmental Meeting on Pandemic Influenza Preparedness
Geneva, Switzerland
15 May 2009
World is better prepared for influenza pandemic
Address to the ASEAN+3 Health Ministers’ Special Meeting on Influenza A(H1N1)
Bangkok, Thailand (Via videoconference)
8 May 2009
Joint FAO/WHO/OIE Statement on influenza A(H1N1) and the safety of pork
Joint FAO/WHO/OIE Statement
7 May 2009
H1N1 influenza situation
Statement made at the Secretary-General’s briefing to the United Nations General Assembly on the H1N1 influenza situation
Via videoconference from Geneva, Switzerland
4 May 2009
Influenza A(H1N1)
Statement by WHO Director-General Dr Margaret Chan
29 April 2009
Swine influenza
Statement by WHO Director-General Dr Margaret Chan
27 April 2009
Swine influenza
Statement by WHO Director-General Dr Margaret Chan
25 April 2009
